Pseudohypoaldosteronism, Type I, Autosomal Recessive

Alternative Names

  • PHA1B
  • PHA I, Autosomal Recessive
Back to search Result
WHO-ICD-10 version:2010

Endocrine, nutritional and metabolic diseases

Disorders of other endocrine glands

OMIM Number

264350

Mode of Inheritance

Autosomal recessive. Also has a dominant form

Gene Map Locus

12p13.31,16p12.2

Description

Pseudohypoaldosteronism Type I (PHA-I) is a rare hereditary disorder of electrolyte metabolism, in which the renal tubules show an apparent loss of response to mineralocorticoids. This condition is characterized by hyperkalemia, metabolic acidosis, hypervolemia, renal salt wasting (or retention), hypotension (or hypertension), and abnormal levels of rennin and aldosterone. The clinical expression of the condition varies from completely asymptomatic individuals, to severely affected infants, in whom the diseases may be lethal. At least two different clinical forms of the disease are known - the purely renal associated PHA-I and a separate form associated with multiple target organ defects (MTOD), in which the kidney, colon, lung, salivary and sweat glands are also affected.

The condition needs to be considered as a differential in the diagnosis of Congenital Adrenal Hypoplasia, especially in boys, due to the similarity of the symptoms. Administration of mineralocorticoids does not seem to work much towards the management of the renal form of the disease. Instead, the condition needs to be treated with fluid and sodium supplementation. The MTOD form is managed by a high-sodium low-potassium diet. In addition, patients exhibiting dyspnea and cyanosis may require external supply of oxygen.

Molecular Genetics

The purely renal form of PHA and the MTOD form show different molecular genetics. The MTOD form of the disease is transmitted in an autosomal recessive fashion with variable degree of penetrance. In many of the families seen to be affected with this condition, mutations have been detected in the genes that code for subunits of the Epithelial Na+ Channels (ENaC). Three separate genes code for the functional ENAC protein, and mutations in any one of these can lead to PHA. These subunits are present at two different loci - 12p13 (SCNN1A), and 16p13-p12 (SCNN1B and SCNN1G).

Epidemiology in the Arab World

View Map
Subject IDCountrySexFamily HistoryParental ConsanguinityHPO TermsVariantZygosityMode of InheritanceReferenceRemarks
264350.1LebanonUnknownYes Hyperkalemia; Hyponatremia; Metabolic ac...NM_000336.3:c.1542+1G>AHomozygousAutosomal, RecessiveJalkh et al. 2019

Other Reports

Kuwait

El Sori (1997) (Kuwait Med J 1997; 29(3):341-4) described a Kuwaiti female infant who suffered from severe salt-wasting and life threatening hyperkalemia. She responded to salt supplements and ion-exchange resin.

Oman

Khan and Manzar (2000) reported a case of a 10-day-old male with normal male genitalia. The infant, born to consanguineous parents, presented with refusal of feeding and excessive crying. He was found to be dehydrated, with hyponatremia and hyperkalemia, which persisted despite fluid resuscitation. Further investigations revealed chloride of 87mmol/L, urea of 44umol/L, glucose of 4.4mmol/L, calcium of 3.22mmol/L, and lactate of 0.88mmol/L, while ABG showed metabolic acidosis (pH: 7.24, pCO2: 2.4 Kpa, PaO2: 9.8Kpa, HCO3: 11.8mmol/L, BE: -17.9mmol/L, and O2 sat: 92.6%). The urinary pH was 5 despite bicarbonate therapy. Renal ultrasound was normal. With the above results, a diagnosis of congenital adrenal hyperplasia was made and the patient was started on mineralocorticoids and a bolus of bicarbonate, followed by hypertonic saline. Further increase in his serum potassium (8.1mmol/L) required administration of a potassium chelator, and a beta-adrenegic receptor agonist. The above diagnosis was then changed to pseudohypoaldosteronism on the basis of findings of normal levels of 17-hydroxyprogesterone, plasma cortisol, urinary 17-ketoacids, and low urinary pregnantriol levels, along with very high levels of serum aldosterone and rennin, and the fact that there was also a family history (two cousins) of pseudohypoaldosteronism. The infant was then prescribed oral hypertonic saline, oral sodium bicarbonate, and a potassium chelator. Upon follow-up, the patient was found to be thriving well, maintaining normal levels of sodium and potassium, and had no acidosis. Khan and Manzar (2000) concluded that the diagnoses of pseudohypoaldosteronism and congenital adrenal hyperplasia should both be considered in any neonate presenting late with dehydration, hyponatremia, and hyperkalemia.

© CAGS 2024. All rights reserved.